Arcus Biosciences Overview
Arcus Biosciences Target Price
Analysts' 12-month price predictions for RCUS.
Get informed when a big investor buys or sells
+ FollowShare Price
$30.33
Average Target Price
$34.67
14.3% upside
14.3% upside3 analysts in the last 4 months
High: $47 | Low: $22
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-18 | Truist Financial | $35 | 15.4% upside |  |
| 2026-05-11 | Morgan Stanley | $22 |  27.5% downside | |
| 2026-04-20 | Leerink Partners | $47 | 55% upside | |
| 2026-02-12 | Wells Fargo | $23 | 24.2% downside | |
| 2026-01-12 | Goldman SachsRichard Law | $28 | 7.7% downside | |
| 2026-01-08 | Morgan Stanley | $20 | 34.1% downside | |
| 2025-12-12 | Truist Financial | $30 | 1.1% downside | |
| 2025-12-12 | H.C. Wainwright | $32 | 5.5% upside | |
| 2025-10-30 | Goldman SachsSalveen Richter | $16 | 47.2% downside | |
| 2025-10-29 | Wedbush | $35 | 15.4% upside | |
| 2025-10-29 | H.C. Wainwright | $28 | 7.7% downside | |
| 2025-10-07 | Truist FinancialAsthika Goonewardene | $39 | 28.6% upside | |
| 2025-05-07 | Wells FargoEva Fortea Verdejo | $26 | 14.3% downside | |
| 2024-10-24 | CitigroupYigal Nochomovitz | $46 | 51.7% upside | |
| 2024-10-21 | H.C. WainwrightEmily Bodnar | $20 | 34.1% downside | |
| 2024-10-08 | Wells FargoEva Fortea Verdejo | $29 | 4.4% downside | |
| 2024-10-08 | Morgan StanleyJudah Frommer | $35 | 15.4% upside | |
| 2024-08-09 | Bank of America SecuritiesJason Zemansky | $23 | 24.2% downside | |
| 2024-07-08 | BarclaysPeter Lawson | $25 | 17.6% downside | |
| 2024-06-24 | Truist FinancialAsthika Goonewardene | $44 | 45.1% upside | |
| 2024-06-04 | BarclaysPeter Lawson | $35 | 15.4% upside | |
| 2022-12-20 | Citigroup | $42 | 38.5% upside | |
| 2022-11-23 | Citigroup | $37 | 22% upside | |
| 2022-05-11 | WedbushRobert Driscoll | $42 | 38.5% upside | |